Literature DB >> 2300544

Effect of aliphatic side-chain substituents on the antimalarial activity and on the metabolism of primaquine studied using mitochondria and microsome preparations.

J K Baker1, R H Yarber, N P Nanayakkara, J D McChesney, F Homo, I Landau.   

Abstract

The substitution of two deuterium atoms on the alpha-carbon of the primaquine side chain was found to produce a sevenfold decrease in the rate of conversion of primaquine to carboxyprimaquine by enzymatic oxidative deamination, but the deuterium substitution was found to have no significant effect on the in vitro antimalarial activity or on in vitro hepatocyte toxicity. Placing a single methyl group on the alpha-carbon was found to produce only a slight decrease in the rate of oxidative deamination. Although metabolic attack occurred adjacent to either the aniline nitrogen or the aliphatic amine, metabolic attack occurred primarily adjacent to the more basic nitrogen at the 1'-position, even when this position bore a methyl substituent. Primaquine, the alpha-dideutero analogue, and the alpha-methyl analogue were all found to have about the same in vitro antimalarial activity as determined in the liver hepatocyte assay.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300544     DOI: 10.1023/a:1015899928897

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Derivatives of 6-nitro- and 6-amino-quinoline.

Authors:  L HASKERBERG
Journal:  J Org Chem       Date:  1947-05       Impact factor: 4.354

2.  Excretion, distribution, and metabolism of primaquine in rats.

Authors:  A M Clark; J K Baker; J D McChesney
Journal:  J Pharm Sci       Date:  1984-04       Impact factor: 3.534

3.  Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.

Authors:  G W Mihaly; S A Ward; G Edwards; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

4.  Antimalarial activity and inhibition of monoamine oxidases A and B by exo-erythrocytic antimalarials. Optical isomers of primaquine, N-acylated congeners, primaquine metabolites and 5-phenoxy-substituted analogues.

Authors:  A Brossi; P Millet; I Landau; M E Bembenek; C W Abell
Journal:  FEBS Lett       Date:  1987-04-20       Impact factor: 4.124

5.  High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite.

Authors:  J K Baker; J D McChesney; C D Hufford; A M Clark
Journal:  J Chromatogr       Date:  1982-06-11

6.  High-performance liquid chromatographic-ultraviolet determination of primaquine and its metabolites in human plasma and urine.

Authors:  G W Parkhurst; M V Nora; R W Thomas; P E Carson
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

7.  Characterization of the urinary metabolites of primaquine in rats.

Authors:  J K Baker; J D McChesney; L F Jorge
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

8.  Metabolism and distribution of primaquine in monkeys.

Authors:  J K Baker; J A Bedford; A M Clark; J D McChesney
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

  8 in total
  4 in total

Review 1.  Amino Acids in the Development of Prodrugs.

Authors:  Nuno Vale; Abigail Ferreira; Joana Matos; Paula Fresco; Maria João Gouveia
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

2.  Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.

Authors:  M J Portela; R Moreira; E Valente; L Constantino; J Iley; J Pinto; R Rosa; P Cravo; V E do Rosário
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

3.  An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model.

Authors:  X Jin; B S Pybus; R Marcsisin; T Logan; T L Luong; J Sousa; N Matlock; V Collazo; C Asher; D Carroll; R Olmeda; L A Walker; M P Kozar; V Melendez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06       Impact factor: 2.441

4.  Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine.

Authors:  Monpat Chamnanphon; Andrea Gaedigk; Apichaya Puangpetch; Ekawat Pasomsub; Wasun Chantratita; Rhea J Longley; Jetsumon Sattabongkot; Pajaree Chariyavilaskul; Chonlaphat Sukasem
Journal:  Pharmgenomics Pers Med       Date:  2020-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.